| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.46▲ | 1.46▲ | 1.46▲ | 1.52▼ | 1.41▲ |
| MA10 | 1.47▲ | 1.49▼ | 1.50▼ | 1.52▼ | 1.43▲ |
| MA20 | 1.53▼ | 1.56▼ | 1.56▼ | 1.43▲ | 1.43▲ |
| MA50 | 1.58▼ | 1.54▼ | 1.51▼ | 1.44▼ | 1.33▲ |
| MA100 | 1.49▼ | 1.45▲ | 1.45▲ | 1.44▼ | 1.80▼ |
| MA200 | 1.43▲ | 1.45▲ | 1.46▲ | 1.38▲ | 2.73▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.017▼ | -0.020▼ | 0.005▲ | -0.004▼ |
| RSI | 33.324▼ | 37.426▼ | 39.659▼ | 48.398▼ | 50.087▲ |
| STOCH | 15.140▼ | 6.104▼ | 5.598▼ | 48.592 | 24.088 |
| WILL %R | -85.714▼ | -85.714▼ | -87.500▼ | -68.293 | -71.739 |
| CCI | -38.050 | -53.926 | -60.882 | -18.961 | 8.206 |
|
Sunday, July 12, 2026 11:48 PM
Merck received a recent U.S. regulatory approval for an oncology treatment combination. The announcement highlights the company’s oncology portfolio, research pipeline, and global pharmaceutical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/07/26 | 1.48 | 1.48 | 1.44 | 1.44 | 21,460 |
| 13/07/26 | 1.51 | 1.53 | 1.45 | 1.46 | 34,634 |
| 10/07/26 | 1.59 | 1.59 | 1.51 | 1.51 | 70,894 |
| 09/07/26 | 1.59 | 1.6093 | 1.56 | 1.58 | 38,954 |
| 08/07/26 | 1.67 | 1.70 | 1.59 | 1.61 | 132,037 |
| 07/07/26 | 1.5399 | 1.72 | 1.52 | 1.68 | 227,990 |
| 06/07/26 | 1.47 | 1.60 | 1.46 | 1.48 | 148,002 |
| 02/07/26 | 1.46 | 1.52 | 1.46 | 1.47 | 53,763 |
| 01/07/26 | 1.46 | 1.498 | 1.45 | 1.45 | 46,548 |
| 30/06/26 | 1.48 | 1.4929 | 1.41 | 1.47 | 51,743 |
|
|
||||
|
|
||||
|
|